Substituted [(5H-pyrrolo[2,1-c] [1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity H1 inverse agonists/5-HT2A antagonists
- 专利权人:
- Eli Lilly and Company
- 发明人:
- Camp, Anne Marie,Gallagher, Peter Thaddeus,Sanderson, Adam Jan,Ledgard, Andrew James,Coates, David Andrew
- 申请号：
- AU2012214788
- 公开号：
- AU2012214788B2
- 申请日:
- 2012.01.25
- 申请国别(地区):
- AU
- 年份:
- 2014
- 代理人:
- 摘要：
- A dual H1/5-HT
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists
- H1 /5-HT2A [5H-[21-c][14]-11--1-]-22- SUBSTITUTED [5H-PYRROLO[21-c][14]BENZODIAZEPIN-11-YLPIPERAZIN-1-YL]-22-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
- (THIENO[2,3-B][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
- compounds (thieno [2,3-b] [1,5] benzoxazepin-4-yl) piperazin-1-yl as h1 inverse agonists / dual-activity 5-ht2a antagonists
- H1 /5-HT2A [23-b][15]-4--1- THIENO[23-b][15]BENZOXAZEPIN-4-YLPIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
